Publicaciones en colaboración con investigadores/as de Erasmus University Rotterdam (7)

2018

  1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2001

  1. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial

    Journal of the American College of Cardiology, Vol. 37, Núm. 6, pp. 1598-1603

  2. Electrophysiologic characteristics in initiation of paroxysmal atrial fibrillation from a focal area

    Journal of the American College of Cardiology, Vol. 37, Núm. 6, pp. 1658-1664

  3. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)

    Circulation, Vol. 104, Núm. 22, pp. 2689-2693

1998

  1. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

    Lancet, Vol. 352, Núm. 9129, pp. 673-681

1996

  1. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the Benestent-II pilot study

    Circulation, Vol. 93, Núm. 3, pp. 412-422

1994

  1. Prevention of restenosis after coronary balloon angioplasty: Rationale and design of the fluvastatin angioplasty restenosis (FLARE) trial

    The American Journal of Cardiology, Vol. 73, Núm. 14